In situ bioelectronics

Diseases of the central nervous system (CNS) remain one of the greatest challenges in modern healthcare, affecting millions worldwide. From neurodegenerative conditions like Parkinson’s and Alzheimer’s to chronic pain and psychiatric disorders, the need for innovative therapies has never been more urgent.

In the in situ bioelectronics projects, we are pioneering a groundbreaking approach to treatment, combining the power of organic bioelectronics with the precision of modern neuroscience. Conventional implants and electrodes rely on insertion of rigid or semi-rigid devices into tissue, causing mild to serious tissue damage and scarring. By developing electrodes and electronic functionality that are formed in situ, within and around nerve cells and tissue, we aim to bridge the gap between electrical and biochemical therapies, creating new opportunities to treat complex brain disorders.

These projects are highly interdisciplinary, bringing together expertise from bioelectronics device development, materials science, chemistry, advanced imaging, and biology.

What we do

• Innovative materials: Designing organic molecules that self-assemble and polymerize in the brain to create functional electronic interfaces.

• Neuropharmacology redefined: Introducing electronic elements to complement traditional biochemical therapies, targeting conditions that resist current treatments.

• Advanced research models: We use a variety of in vitro and in vivo models to test and refine our technologies.

Our vision

We envision a future where neurodegenerative diseases and CNS disorders can be addressed through seamless integration of electronics and biology. From diagnostic tools to therapeutic interventions, in situ bioelectronics seeks to redefine the limits of what is possible in brain health.